Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-19 Purchase |
2020-11-20 3:56 pm |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
10,000 | $16.22 | $162,200 | 94,722 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Option Award |
2024-06-17 4:13 pm |
N/A 2034-06-13 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
130,000 | $0 | 130,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-23 6:18 pm |
N/A 2034-05-21 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
36,490 | $0 | 36,490 (Direct) |
View |
| 2024-04-05 Equity Swap |
2024-04-08 4:16 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | RIEFLIN WILLIAM JL Director |
2,774,340 | $0 | 0 (Direct) |
View |
| 2024-03-28 Option Award |
2024-04-01 6:48 pm |
N/A 2034-03-27 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
11,871 | $7.58 | 11,871 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-08 4:27 pm |
N/A 2033-09-07 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 4:51 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 7:00 pm |
N/A 2033-05-23 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
12,940 | $0 | 12,940 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 5:52 pm |
N/A 2033-05-09 |
NGM BIOPHARMACEUTICALS INC | NGM | RIEFLIN WILLIAM JL Director |
78,407 | $0 | 78,407 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-10 8:10 pm |
N/A 2033-03-30 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
6,026 | $14.52 | 6,026 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:20 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:18 pm |
N/A 2032-05-24 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
8,500 | $0 | 8,500 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 5:58 pm |
N/A 2032-03-30 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
5,207 | $16.8 | 5,207 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-04 4:11 pm |
N/A 2032-03-02 |
NGM BIOPHARMACEUTICALS INC | NGM | RIEFLIN WILLIAM JL Executive Chairman |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-24 8:17 pm |
N/A 2031-05-27 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
7,500 | $0 | 7,500 (Direct) |
View |
Ownership |
2021-06-16 7:22 pm |
N/A 2030-05-18 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
0 | $0 | 400,000 (Direct) |
View |
| 2021-03-17 Option Award |
2021-03-18 8:22 pm |
N/A 2031-03-16 |
NGM BIOPHARMACEUTICALS INC | NGM | RIEFLIN WILLIAM JL Executive Chairman |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 5:44 pm |
N/A 2030-06-17 |
RAPT Therapeutics Inc. | RAPT | RIEFLIN WILLIAM JL Director |
7,500 | $0 | 7,500 (Direct) |
View |